More reads
- Celgene odds are in investors' favor. (Wall Street Journal)
- Nightstar gives Biogen a cheap way to expand in gene therapy. (EP Vantage)
- ITC agrees to investigate Allergan claims that Botox rivals stole secrets. (STAT Plus)
- Startups focusing on aging have a home in new Kendall Square incubator. (Boston Globe)
.png)
No hay comentarios:
Publicar un comentario